Neonatal Meningitis (Streptococcus agalactiae - Group B Streptococcus)
Overview
Plain-Language Overview
Neonatal meningitis is a serious infection that affects the protective membranes covering a newborn baby's brain and spinal cord. It is most commonly caused by the bacteria Group B Streptococcus (GBS), which can be passed from mother to baby during childbirth. This infection primarily involves the central nervous system and can lead to symptoms such as fever, irritability, poor feeding, and difficulty breathing. If untreated, it can cause severe complications including brain damage, hearing loss, or even death. Early recognition and diagnosis are critical to managing this condition effectively. The infection disrupts normal brain function by causing inflammation and swelling in the meninges, the thin layers surrounding the brain and spinal cord.
Clinical Definition
Neonatal meningitis is an infection characterized by inflammation of the meninges in newborns, typically occurring within the first 28 days of life. The most common causative agent is Streptococcus agalactiae (Group B Streptococcus), which colonizes the maternal genital tract and is transmitted vertically during delivery. The pathogenesis involves bacterial invasion of the bloodstream followed by crossing the blood-brain barrier, leading to meningeal inflammation. Clinically, it presents with nonspecific signs such as fever, lethargy, poor feeding, and respiratory distress. The condition is a major cause of neonatal morbidity and mortality worldwide. Diagnosis and prompt treatment are essential to prevent long-term neurological sequelae such as hydrocephalus, seizures, and developmental delay.
Inciting Event
Vertical transmission of Streptococcus agalactiae during passage through the birth canal.
Ascending infection following premature rupture of membranes or prolonged labor.
Inadequate intrapartum antibiotic prophylaxis in colonized mothers allows bacterial transmission.
Intra-amniotic infection leading to fetal exposure to bacteria in utero.
Latency Period
Early-onset neonatal meningitis typically presents within the first 24-72 hours after birth.
Late-onset disease can occur from 7 days to 3 months of age, often from nosocomial or community sources.
Symptoms usually develop rapidly after bacterial exposure due to rapid bacterial proliferation.
Diagnostic Delay
Nonspecific early symptoms such as irritability and poor feeding delay recognition.
Overlap with other neonatal infections like sepsis or pneumonia complicates diagnosis.
Lack of maternal screening or unknown colonization status delays suspicion.
Subtle or absent fever in neonates can lead to underestimation of severity.
Clinical Presentation
Signs & Symptoms
Fever or hypothermia in neonates with meningitis
Irritability and high-pitched crying
Apnea or respiratory distress
Seizures indicating CNS involvement
Poor feeding and vomiting
Lethargy or decreased responsiveness
History of Present Illness
Poor feeding, lethargy, and irritability are common initial symptoms.
Fever or hypothermia may be present but is often inconsistent in neonates.
Respiratory distress and apnea can develop as infection progresses.
Seizures and bulging fontanelle indicate advanced meningeal involvement.
Rapid clinical deterioration with signs of sepsis and shock may occur.
Past Medical History
Maternal Group B Streptococcus colonization or previous infant with GBS disease increases risk.
Premature rupture of membranes or prolonged labor history is relevant.
Preterm birth or low birth weight history predisposes to severe infection.
Lack of intrapartum antibiotic prophylaxis in prior deliveries is significant.
Family History
There is no strong heritable predisposition to neonatal meningitis caused by Group B Streptococcus.
Family history is generally not contributory to risk or presentation.
Rare immunodeficiency syndromes in family may increase susceptibility but are uncommon.
Physical Exam Findings
Bulging fontanelle indicating increased intracranial pressure in neonates
Poor feeding and lethargy reflecting systemic illness
Hypotonia and decreased spontaneous movements
Seizures may be observed as focal or generalized convulsions
Respiratory distress due to systemic infection or sepsis
Diagnostic Workup
Diagnostic Criteria
Diagnosis of neonatal meningitis relies on cerebrospinal fluid (CSF) analysis obtained via lumbar puncture, showing elevated white blood cell count, decreased glucose, and increased protein levels. Identification of Group B Streptococcus by CSF culture or Gram stain confirms the diagnosis. Blood cultures are also important for detecting bacteremia. Clinical signs combined with laboratory findings and positive microbiological tests establish the diagnosis. Neuroimaging may be used to assess complications but is not diagnostic.
Pathophysiology
Key Mechanisms
Hematogenous spread of Streptococcus agalactiae from maternal genital tract to neonate causes meningeal infection.
Bacterial invasion of the blood-brain barrier leads to inflammation of the meninges and cerebrospinal fluid (CSF) pleocytosis.
Neutrophilic infiltration and release of proinflammatory cytokines cause meningeal edema and increased intracranial pressure.
Capsular polysaccharide of Group B Streptococcus enables immune evasion and promotes bacterial survival in the bloodstream.
Endotoxin-mediated endothelial damage contributes to blood-brain barrier disruption and neuronal injury.
| Involvement | Details |
|---|---|
| Organs | Brain is the primary organ affected, with inflammation causing neuronal injury, increased intracranial pressure, and potential long-term neurological sequelae. |
Kidneys require monitoring during treatment due to potential nephrotoxicity from aminoglycoside antibiotics. | |
| Tissues | Meninges are inflamed in neonatal meningitis, leading to characteristic clinical signs such as neck stiffness and irritability. |
Choroid plexus tissue may be involved as a site of bacterial entry and inflammation within the CNS. | |
| Cells | Neutrophils are the primary immune cells infiltrating the cerebrospinal fluid, mediating bacterial clearance and inflammation. |
Microglia act as resident CNS macrophages, contributing to the inflammatory response and phagocytosis of bacteria. | |
Endothelial cells of the blood-brain barrier become activated and more permeable, facilitating leukocyte migration into the CNS. | |
| Chemical Mediators | Interleukin-1 (IL-1) is a pro-inflammatory cytokine elevated in cerebrospinal fluid, promoting fever and leukocyte recruitment. |
Tumor necrosis factor-alpha (TNF-α) amplifies the inflammatory response and contributes to blood-brain barrier disruption. | |
Prostaglandins mediate fever and vasodilation during the inflammatory process in meningitis. |
Treatments
Pharmacological Treatments
Ampicillin
- Mechanism:
Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis.
- Side effects:
Allergic reactions
Diarrhea
Rash
- Clinical role:
First-line
Gentamicin
- Mechanism:
Binds to the 30S ribosomal subunit, causing misreading of mRNA and inhibiting bacterial protein synthesis.
- Side effects:
Nephrotoxicity
Ototoxicity
Neuromuscular blockade
- Clinical role:
First-line
Cefotaxime
- Mechanism:
Third-generation cephalosporin that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.
- Side effects:
Hypersensitivity reactions
Diarrhea
Elevated liver enzymes
- Clinical role:
Alternative first-line
Non-pharmacological Treatments
Supportive care including maintenance of airway, breathing, and circulation is essential in managing neonatal meningitis.
Intravenous fluid management to maintain hydration and electrolyte balance is critical during treatment.
Monitoring and management of intracranial pressure may be necessary in severe cases.
Prevention
Pharmacological Prevention
Intrapartum intravenous penicillin or ampicillin prophylaxis to GBS-colonized mothers
Use of ampicillin and gentamicin empirically in neonates at risk
Prompt initiation of targeted antibiotics upon diagnosis to prevent progression
Non-pharmacological Prevention
Universal screening of pregnant women for GBS colonization at 35-37 weeks gestation
Proper aseptic technique during delivery and neonatal care
Early identification and monitoring of neonates born to GBS-positive mothers
Avoidance of prolonged rupture of membranes to reduce vertical transmission
Outcome & Complications
Complications
Septic shock due to systemic infection
Hydrocephalus from impaired CSF flow
Brain abscess or ventriculitis
Disseminated intravascular coagulation (DIC)
Multiorgan failure in severe cases
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Neonatal Meningitis (Streptococcus agalactiae - Group B Streptococcus) versus Neonatal Meningitis (Escherichia coli)
Neonatal Meningitis (Streptococcus agalactiae - Group B Streptococcus) | Neonatal Meningitis (Escherichia coli) |
|---|---|
Gram-positive cocci in chains, beta-hemolytic, group B antigen positive | Gram-negative rod commonly causing neonatal meningitis, especially in preterm infants |
Often associated with maternal vaginal colonization by group B streptococcus | Often associated with maternal urinary tract infections or prolonged rupture of membranes |
Typically sensitive to penicillin and ampicillin-based regimens | May require addition of aminoglycosides due to resistance patterns |
Neonatal Meningitis (Streptococcus agalactiae - Group B Streptococcus) versus Neonatal Meningitis (Listeria monocytogenes)
Neonatal Meningitis (Streptococcus agalactiae - Group B Streptococcus) | Neonatal Meningitis (Listeria monocytogenes) |
|---|---|
Gram-positive cocci in chains, extracellular pathogen | Gram-positive rod, facultative intracellular pathogen |
Associated with maternal vaginal colonization without specific food exposure | Associated with maternal ingestion of unpasteurized dairy or contaminated food |
Typically presents within first week of life | Can present in early or late neonatal period, often within first week |
Usually treated with ampicillin alone or with gentamicin | Requires ampicillin plus gentamicin for effective treatment |
Neonatal Meningitis (Streptococcus agalactiae - Group B Streptococcus) versus Neonatal Meningitis (Herpes Simplex Virus)
Neonatal Meningitis (Streptococcus agalactiae - Group B Streptococcus) | Neonatal Meningitis (Herpes Simplex Virus) |
|---|---|
Gram-positive bacterial cocci causing meningitis | Double-stranded DNA virus causing meningoencephalitis |
Positive bacterial culture or antigen test for group B streptococcus | Positive PCR for viral DNA in cerebrospinal fluid |
Presents with fever, irritability, and nonspecific signs of bacterial meningitis | Often presents with seizures and focal neurological signs |
Neonatal Meningitis (Streptococcus agalactiae - Group B Streptococcus) versus Neonatal Meningitis (Klebsiella species)
Neonatal Meningitis (Streptococcus agalactiae - Group B Streptococcus) | Neonatal Meningitis (Klebsiella species) |
|---|---|
Gram-positive cocci in chains, sensitive to beta-lactams | Gram-negative encapsulated rod, often multidrug resistant |
Often community-acquired from maternal colonization | More common in hospital-acquired infections or NICU settings |
Responds well to ampicillin and gentamicin | May require carbapenems due to extended-spectrum beta-lactamase production |